Skip to main content
Sona Nanotech Inc. logo

Sona Nanotech Inc. — Investor Relations & Filings

Ticker · SONA ISIN · CA83541C1059 CSE Professional, scientific and technical activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2024-03-25 Regulatory Filings
Country CA Canada
Listing CSE SONA

About Sona Nanotech Inc.

https://www.sonanano.com/

Sona Nanotech Inc. is a life sciences company specializing in the development and commercialization of proprietary, uniquely biocompatible gold nanorod (GNR) technology. The primary therapeutic focus is Targeted Hyperthermia Therapy (THT), a photothermal cancer treatment utilizing GNRs to deliver precision heat directly to solid tumors. THT is designed to reduce tumor burden and stimulate immunogenic cell death while minimizing harm to healthy tissue. Sona is advancing THT through clinical trials for solid cancers, including melanoma. Furthermore, the company manufactures and supplies its patented, CTAB-free gold nanoparticles (nanorods and nanospheres) for integration into advanced materials science and medical diagnostic applications, such as lateral flow assays.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release from Sona Nanotech providing an update on interim results from a scientific study and new laboratory results from the National Cancer Institute's Nanotechnology Characterization Laboratory. It discusses research progress, study findings, and potential future regulatory applications but does not contain financial data, regulatory filings, or formal report content. There is no indication that this is a formal financial report, audit, earnings release, or regulatory filing. It is an informational update on scientific and product development progress, typical of a general corporate announcement or news release. Given the content and context, it best fits under Regulatory Filings (RNS) as a general regulatory announcement or corporate update that does not fit other specific categories.
2024-03-25 English
Notice of meeting - English.pdf
Regulatory Filings
2024-03-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the filing of a provisional patent application by Sona Nanotech Inc. It discusses the development of a medical device and ongoing pre-clinical studies, as well as recent meetings with regulatory bodies and advisory board appointments. There is no financial data, earnings information, regulatory certifications, or report attachments. The content is primarily an update on intellectual property and company developments, not a financial or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement related to company activities and intellectual property, which does not match any specific financial filing category. Therefore, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other categories.
2024-03-18 English
News release - English.pdf
Regulatory Filings
2024-03-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-502F1' and is a Management Certification related to participation fees for Class 1 and Class 3B reporting issuers, submitted to the Ontario Securities Commission. It contains certification by an officer (Chief Financial Officer) confirming the accuracy of the information provided, including market value calculations and fee amounts. The content is primarily a certification and fee calculation form rather than a financial report or detailed management discussion. It does not contain substantive financial statements or detailed financial analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is an official regulatory submission and certification rather than a full report or announcement of a report.
2024-02-27 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE' and includes a management certification by the CFO of Sona Nanotech Inc. It provides detailed market value calculations of equity securities over specified trading periods and concludes with a participation fee amount payable. The document is a regulatory form submitted to the Alberta Securities Commission, certifying completeness and accuracy of the information. It is primarily a certification and fee calculation form related to securities market value reporting, not a financial report, earnings release, or other typical corporate filing. The presence of a management certification and the nature of the form indicate it is a regulatory filing rather than a financial report or announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-02-27 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.